Infection Prevention and Control
Stay informed on the latest news and developments in infection prevention and control. AHA provides valuable resources and support to help you maintain a safe and clean environment.
Trusted collaboration among all stakeholders, coupled with a clear consensus for keeping health care teams and patients safe, drive the infection prevention efforts at Missouri Baptist Sullivan Hospital.
The Centers for Disease Control and Prevention alerted clinicians to an outbreak of suspected fungal meningitis among U.S. patients hospitalized in Texas after undergoing cosmetic procedures under epidural anesthesia at clinics in Matamoros, Mexico.
Here’s a look at some breakthrough advances cited by the Association of American Medical Colleges (AAMC) that are designed to help providers tackle some of the most complex diseases.
A Letter from AHA Leaders on Infection Prevention and Control
As a leading health care organization serving hospitals and health systems across the country, the American Hospital Association continually looks for opportunities to gain feedback from our members so we can effectively meet their…
Every year, thousands of patients across the United States are impacted by the effects of hospital-onset Clostridioides difficile (C. diff) infections (HO-CDIs). In this webinar, we examine the limitations of current interventions to prevent transmission of C. diff. We also present the manner in…
Forty-nine cities and states with the highest HIV transmission rates yesterday received between $2 million and $17 million each in fiscal year 2023 grants from the Health Resources and Services Administration to diagnose, treat and prevent new HIV infections as part of a Department of Health and…
The Food and Drug Administration approved the first fecal microbiota product taken orally to prevent recurrent C. difficile infection.
Learn how Advocate Children's Hospital is managing the “immunity gap” created by social distancing to persevere through the triple threat of COVID-19, RSV and flu.
Candida auris fungal infections tripled in the United States between 2019 and 2021 to 1,471, including seven cases resistant to all antifungal treatments, according to Centers for Disease Control and Prevention data reported yesterday in the Annals of Internal Medicine.
Sources of hospital onset bacteremia (HOB), its identification, how effectively HOB can be prevented, treated and considerations for quality metrics.